Immuto Scientific is developing a platform that integrates artificial intelligence with mass spectrometry to accelerate protein structure determination. The company, co-founded in 2018 by CEO Faraz A. Choudhury and CTO Daniel Benjamin, focuses on streamlining workflows for analyzing antibody-antigen complexes. Its approach is designed to address significant bottlenecks in traditional cryo-electron microscopy methods.